CNO CAO granted 2,100 restricted stock units

CNO Financial Group Chief Accounting Officer Joel T. Koehneman received a grant of 2,100 restricted stock units on February 10, 2026.

Rhea-AI Filing Summary

CNO Financial Group Chief Accounting Officer Joel T. Koehneman received a grant of 2,100 restricted stock units on February 10, 2026. These units were awarded at a price of $0 per unit and increased his directly held restricted stock unit balance to 5,292.

The restricted stock units convert into common stock on a one-for-one basis. They vest in three equal annual installments beginning March 25, 2027, as long as Koehneman remains employed by CNO Financial Group or one of its subsidiaries.

Insider Trade Summary

Grant/Award: 2,100 shares

Grant/Award 1 txn

Insider Koehneman Joel T.

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	2,100	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 5,292 shares (Direct)

Footnotes (2)

1. F1. Restricted stock units convert into common stock on a one-for-one basis.
2. F2. The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CNO (CNO) report in this Form 4 filing?

The filing reports that Chief Accounting Officer Joel T. Koehneman received a grant of 2,100 restricted stock units on February 10, 2026. These units were awarded at a price of $0 per unit and increased his directly held restricted stock unit holdings to 5,292.

How many restricted stock units did Joel T. Koehneman receive from CNO (CNO)?

Joel T. Koehneman received 2,100 restricted stock units as an award from CNO Financial Group. This acquisition increased his total directly held restricted stock units to 5,292, reflecting his equity-based compensation as Chief Accounting Officer of the company.

What is the vesting schedule for Joel T. Koehneman’s CNO (CNO) restricted stock units?

The restricted stock units vest in three equal annual installments beginning March 25, 2027. Vesting is conditioned on continued employment with CNO Financial Group or one of its subsidiaries, meaning units are earned over time rather than immediately.

How do the CNO (CNO) restricted stock units convert into common stock?

Each restricted stock unit converts into one share of CNO Financial Group common stock on a one-for-one basis. This means that, once vested and settled, the 2,100 units could translate into 2,100 shares of common stock, subject to plan and award terms.

What is Joel T. Koehneman’s role at CNO (CNO) related to this equity grant?

Joel T. Koehneman serves as Chief Accounting Officer of CNO Financial Group and is an officer reporting person. The 2,100 restricted stock units reported in the Form 4 represent equity-based compensation tied to his executive role at the company.

What is Koehneman’s total restricted stock unit holding after this CNO (CNO) transaction?

After the February 10, 2026 grant, Joel T. Koehneman beneficially owns 5,292 restricted stock units directly. This total includes the newly awarded 2,100 units and reflects his accumulated unvested equity awards under CNO Financial Group’s compensation programs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 05:20 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koehneman Joel T.

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Stock Units(1)(2)	02/10/2026		A		2,100	A	$0	5,292	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.